A citation-based method for searching scientific literature

Joan L Kramer, Isela A Velazquez, Bingshu E Chen, Philip S Rosenberg, Jeffery P Struewing, Mark H Greene. J Clin Oncol 2005
Times Cited: 96



J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
Times Cited: 1634




List of shared articles



Times cited

RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.
Antonis C Antoniou, Olga M Sinilnikova, Jacques Simard, Mélanie Léoné, Martine Dumont, Susan L Neuhausen, Jeffery P Struewing, Dominique Stoppa-Lyonnet, Laure Barjhoux, David J Hughes,[...]. Am J Hum Genet 2007
192


Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
487


Local approaches to hereditary breast cancer.
B T Cooper, J O Murphy, V Sacchini, S C Formenti. Ann Oncol 2013
4

Characterization of BRCA1 and BRCA2 mutations in a large United States sample.
Sining Chen, Edwin S Iversen, Tara Friebel, Dianne Finkelstein, Barbara L Weber, Andrea Eisen, Leif E Peterson, Joellen M Schildkraut, Claudine Isaacs, Beth N Peshkin,[...]. J Clin Oncol 2006
218


Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
Julie D Lamb, Rochelle L Garcia, Barbara A Goff, Pamela J Paley, Elizabeth M Swisher. Am J Obstet Gynecol 2006
65

Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction.
B A M Heemskerk-Gerritsen, C Seynaeve, C J van Asperen, M G E M Ausems, J M Collée, H C van Doorn, E B Gomez Garcia, C M Kets, F E van Leeuwen, H E J Meijers-Heijboer,[...]. J Natl Cancer Inst 2015
115

Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.
James D Fackenthal, Olufunmilayo I Olopade. Nat Rev Cancer 2007
283

Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy.
J V Cohen, L Chiel, L Boghossian, M Jones, J E Stopfer, J Powers, T R Rebbeck, K L Nathanson, S M Domchek. Fam Cancer 2012
36


Prophylactic mastectomy in familial breast carcinoma. What do the pathologic findings learn us?
Karin Leunen, Maria Drijkoningen, Patrick Neven, Maria-Rose Christiaens, Chantal Van Ongeval, Eric Legius, Frédéric Amant, Patrick Berteloot, Ignace Vergote. Breast Cancer Res Treat 2008
7

Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
George U Eleje, Ahizechukwu C Eke, Ifeanyichukwu U Ezebialu, Joseph I Ikechebelu, Emmanuel O Ugwu, Onyinye O Okonkwo. Cochrane Database Syst Rev 2018
30

Fertility issues and options in young women with cancer.
K Oktay, M Sönmezer. Recent Results Cancer Res 2008
6


Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
836

Development and evaluation of a decision aid for BRCA carriers with breast cancer.
Julie O Culver, Deborah J MacDonald, Andrea A Thornton, Sharon R Sand, Marcia Grant, Deborah J Bowen, Harry Burke, Nellie Garcia, Kelly A Metcalfe, Jeffrey N Weitzel. J Genet Couns 2011
20

Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers.
Kerstin Rhiem, Dolores Foth, Barbara Wappenschmidt, Heidrun Gevensleben, Reinhard Büttner, Uwe Ulrich, Rita K Schmutzler. Arch Gynecol Obstet 2011
27

Evolution of the colored eco-genetic relationship map (CEGRM) for assessing social functioning in women in hereditary breast-ovarian (HBOC) families.
June A Peters, Lindsey Hoskins, Sheila Prindiville, Regina Kenen, Mark H Greene. J Genet Couns 2006
13

Bias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks of BRCA1/2 Mutation Carriers.
Janet R Vos, Li Hsu, Richard M Brohet, Marian J E Mourits, Jakob de Vries, Kathleen E Malone, Jan C Oosterwijk, Geertruida H de Bock. J Clin Oncol 2015
16

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.
Heidi D Nelson, Miranda Pappas, Bernadette Zakher, Jennifer Priest Mitchell, Leila Okinaka-Hu, Rongwei Fu. Ann Intern Med 2014
153


Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
Noah D Kauff, Susan M Domchek, Tara M Friebel, Mark E Robson, Johanna Lee, Judy E Garber, Claudine Isaacs, D Gareth Evans, Henry Lynch, Rosalind A Eeles,[...]. J Clin Oncol 2008
353